Implicit Biosciences, Eli Lilly deal

Implicit acquired exclusive, worldwide rights to Eli Lilly's IC14 for an undisclosed sum, including

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE